Investigations
Evolv Technologies Holdings, Inc.
Overview
Overview
- Deadline:
- Upcoming
| Company Name: | Company Name: Evolv Technologies Holdings, Inc. |
| Stock Symbol: | Stock Symbol: EVLV |
Evolv Technologies Holdings, Inc. (NASDAQ: EVLV): Evolv is being investigated for violations of the federal securities laws in connection with potential false and misleading statements made to investors and a subsequent significant price decline in the stock.
If you incurred losses on your investments in Evolv, you are encouraged to submit your information.
Why is Evolv being Investigated?
On October 25, 2024, Evolv announced a delay in filing its upcoming quarterly financial report due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022. Evolv also announced that certain financial statements from 2022 to mid-2024 should not be relied upon, as sales to channel partners, including one of Evolv’s largest channel partners, involved undisclosed terms impacting reported revenue. On October 31, 2024, Evolv announced that it had terminated CEO Peter George due to the improper revenue recognition.
The Stock Declines as the Truth is Revealed
The news has caused a precipitous decline in the price of Evolv stock. During trading on October 25, 2024, the price of Evolv stock declined more than 40%. During trading on October 31, 2024, the price of Evolv stock declined more than 10%.
What are my Rights?
If you incurred losses on your investments in Evolv, you are encouraged to submit your information to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
If you incurred losses on your investments in Evolv, you are encouraged to submit your information.
Why is Evolv being Investigated?
On October 25, 2024, Evolv announced a delay in filing its upcoming quarterly financial report due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022. Evolv also announced that certain financial statements from 2022 to mid-2024 should not be relied upon, as sales to channel partners, including one of Evolv’s largest channel partners, involved undisclosed terms impacting reported revenue. On October 31, 2024, Evolv announced that it had terminated CEO Peter George due to the improper revenue recognition.
The Stock Declines as the Truth is Revealed
The news has caused a precipitous decline in the price of Evolv stock. During trading on October 25, 2024, the price of Evolv stock declined more than 40%. During trading on October 31, 2024, the price of Evolv stock declined more than 10%.
What are my Rights?
If you incurred losses on your investments in Evolv, you are encouraged to submit your information to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.